Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
U Deniz DincerDepartment of Pharmacology, Ufuk University School of Medicine. Mevlana Bulvari, Balgat, Ankara, TurkeyAbstract: Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome i...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/12d8b20c84574c369ff7c6f48d103471 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|